Skip to main content
. 2022 Jul 29;98(7):336–360. doi: 10.2183/pjab.98.018

Table 8.

Inhibitory and chaperone activity of various N-alkyl conduramine F-4 against wild-type and mutant human β-galactosidaseInline graphic

R IC50 (µM) against wild type Enhanced activity (fold) of the R201C mutant with N-alkyl-conduramine F-4 derivatives (20 µM)
(a) n-Butyl 50 2.0
n-Pentyl 19 4.0
n-Hexyl 56 4.6
n-Octyl (175) 120 5.4
n-Decyl 43 1.6
(b) (CH2)3OH >1000 0.9
CHEt2 >1000 1.2
Cy 490 1.4
(c) CH2CHEt2 (176) 15 7.4
CH2Cy (28) 60 8.5
CH2CHMe2 41 4.6
CH2Ph 180 1.5
(CH2)2CHMe2 28 4.6
(CH2)2Ph 86 4.2